Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Oncology
Join Editorial Board Propose a Special Issue
Print ISSN: 1019-6439 Online ISSN: 1791-2423
Journal Cover
April-2018 Volume 52 Issue 4

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
April-2018 Volume 52 Issue 4

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Enhancement of malignant properties of human glioma cells by ganglioside GD3/GD2

  • Authors:
    • Taiji Iwasawa
    • Pu Zhang
    • Yuki Ohkawa
    • Hiroyuki Momota
    • Toshihiko Wakabayashi
    • Yuhsuke Ohmi
    • Robiul H. Bhuiyan
    • Keiko Furukawa
    • Koichi Furukawa
  • View Affiliations / Copyright

    Affiliations: Department of Biochemistry II, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan, Department of Biomedical Sciences, Chubu University College of Life and Health Sciences, Kasugai, Aichi 487-8501, Japan, Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan
  • Pages: 1255-1266
    |
    Published online on: February 7, 2018
       https://doi.org/10.3892/ijo.2018.4266
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Sialic acid-containing glycosphingolipids, gangliosides, are considered as cancer associated antigens in neuro-ectoderm-derived tumors such as melanomas and neuroblastomas. In particular, gangliosides GD3 and GD2 are expressed in human gliomas. It has been reported that their expression levels increase along with increased malignant properties. However, the implication of GD3/GD2 in human glioma cells has never been clarified, at least to the best of our knowledge. In this study, we introduced the cDNA of GD3 synthase (GD3S)(ST8SIA1) into a glioma cell line, U-251MG, that expresses neither GD3 nor GD2, thereby establishing transfectant cells U-251MG-GD3S(+) expressing high levels of GD3 and GD2 on the cell surface. In these U-251MG‑GD3S(+) cell lines, signaling molecules such as Erk1/2, Akt, p130Cas, paxillin and focal adhesion kinase were activated, leading to the enhancement of invasion activity and motility. It was then demonstrated that the U-251MG-GD3S(+) cells could proliferate under culture conditions with low or no serum concentrations without undergoing cell cycle arrest by escaping the accumulation of p16 and p21. All these results suggested that GD3 and GD2 highly expressed in gliomas confer increased invasion and mobility, cell growth abilities under low serum conditions, and increased ratios of the S-G2/M phase in the cell cycle.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

View References

1 

Greene LA, Lee HY and Angelastro JM: The transcription factor ATF5: Role in neurodevelopment and neural tumors. J Neurochem. 108:11–22. 2009. View Article : Google Scholar :

2 

Schiffer D, Annovazzi L, Caldera V and Mellai M: On the origin and growth of gliomas. Anticancer Res. 30:1977–1998. 2010.PubMed/NCBI

3 

Huse JT and Holland EC: Targeting brain cancer: Advances in the molecular pathology of malignant glioma and medulloblastoma. Nat Rev Cancer. 10:319–331. 2010. View Article : Google Scholar : PubMed/NCBI

4 

Zong H, Verhaak RG and Canoll P: The cellular origin for malignant glioma and prospects for clinical advancements. Expert Rev Mol Diagn. 12:383–394. 2012. View Article : Google Scholar : PubMed/NCBI

5 

Xie Q, Mittal S and Berens ME: Targeting adaptive glioblastoma: An overview of proliferation and invasion. Neuro Oncol. 16:1575–1584. 2014. View Article : Google Scholar : PubMed/NCBI

6 

Woehrer A, Bauchet L and Barnholtz-Sloan JS: Glioblastoma survival: Has it improved? Evidence from population-based studies. Curr Opin Neurol. 27:666–674. 2014.PubMed/NCBI

7 

Wiegandt H: Gangliosides. Glycolipids. Wiegandt H: 10. Elsevier Science Publishers; Amsterdam: pp. 199–260. 1985, View Article : Google Scholar

8 

Yu RK, Bieberich E, Xia T and Zeng G: Regulation of ganglioside biosynthesis in the nervous system. J Lipid Res. 45:783–793. 2004. View Article : Google Scholar : PubMed/NCBI

9 

Schengrund CL: Gangliosides: Glycosphingolipids essential for normal neural development and function. Trends Biochem Sci. 40:397–406. 2015. View Article : Google Scholar : PubMed/NCBI

10 

Yates AJ: Gangliosides in the nervous system during development and regeneration. Neurochem Pathol. 5:309–329. 1986. View Article : Google Scholar : PubMed/NCBI

11 

Hakomori S: Philip Levine award lecture: Blood group glycolipid antigens and their modifications as human cancer antigens. Am J Clin Pathol. 82:635–648. 1984. View Article : Google Scholar : PubMed/NCBI

12 

Lloyd KO: Humoral immune responses to tumor-associated carbohydrate antigens. Semin Cancer Biol. 2:421–431. 1991.PubMed/NCBI

13 

Schulz G, Cheresh DA, Varki NM, Yu A, Staffileno LK and Reisfeld RA: Detection of ganglioside GD2 in tumor tissues and sera of neuroblastoma patients. Cancer Res. 44:5914–5920. 1984.PubMed/NCBI

14 

Saito M, Yu RK and Cheung NK: Ganglioside GD2 specificity of monoclonal antibodies to human neuroblastoma cell. Biochem Biophys Res Commun. 127:1–7. 1985. View Article : Google Scholar : PubMed/NCBI

15 

Merritt WD, Casper JT, Lauer SJ and Reaman GH: Expression of GD3 ganglioside in childhood T-cell lymphoblastic malignancies. Cancer Res. 47:1724–1730. 1987.PubMed/NCBI

16 

Siddiqui B, Buehler J, DeGregorio MW and Macher BA: Differential expression of ganglioside GD3 by human leukocytes and leukemia cells. Cancer Res. 44:5262–5265. 1984.PubMed/NCBI

17 

Cheresh DA, Rosenberg J, Mujoo K, Hirschowitz L and Reisfeld RA: Biosynthesis and expression of the disialoganglioside GD2, a relevant target antigen on small cell lung carcinoma for monoclonal antibody-mediated cytolysis. Cancer Res. 46:5112–5118. 1986.PubMed/NCBI

18 

Yoshida S, Fukumoto S, Kawaguchi H, Sato S, Ueda R, Furukawa K and Ganglioside G: Ganglioside G(D2) in small cell lung cancer cell lines: Enhancement of cell proliferation and mediation of apoptosis. Cancer Res. 61:4244–4252. 2001.PubMed/NCBI

19 

Azuma K, Tanaka M, Uekita T, Inoue S, Yokota J, Ouchi Y and Sakai R: Tyrosine phosphorylation of paxillin affects the metastatic potential of human osteosarcoma. Oncogene. 24:4754–4764. 2005. View Article : Google Scholar : PubMed/NCBI

20 

Shibuya H, Hamamura K, Hotta H, Matsumoto Y, Nishida Y, Hattori H and Furukawa K, Ueda M and Furukawa K: Enhancement of malignant properties of human osteosarcoma cells with disialyl gangliosides GD2/GD3. Cancer Sci. 103:1656–1664. 2012. View Article : Google Scholar : PubMed/NCBI

21 

Cazet A, Bobowski M, Rombouts Y, Lefebvre J, Steenackers A, Popa I, Guérardel Y, Le Bourhis X, Tulasne D and Delannoy P: The ganglioside G(D2) induces the constitutive activation of c-Met in MDA-MB-231 breast cancer cells expressing the G(D3) synthase. Glycobiology. 22:806–816. 2012. View Article : Google Scholar : PubMed/NCBI

22 

Furukawa K, Akagi T, Nagata Y, Yamada Y, Shimotohno K, Cheung NK, Shiku H and Furukawa K: GD2 ganglioside on human T-lymphotropic virus type I-infected T cells: Possible activation of beta-1,4-N-acetylgalactosaminyltransferase gene by p40tax. Proc Natl Acad Sci USA. 90:1972–1976. 1993. View Article : Google Scholar : PubMed/NCBI

23 

Fredman P, von Holst H, Collins VP, Ammar A, Dellheden B, Wahren B, Granholm L and Svennerholm L: Potential ganglioside antigens associated with human gliomas. Neurol Res. 8:123–126. 1986. View Article : Google Scholar : PubMed/NCBI

24 

Wikstrand CJ, Fredman P, Svennerholm L and Bigner DD: Detection of glioma-associated gangliosides GM2, GD2, GD3, 3′-isoLM1 3′,6′-isoLD1 in central nervous system tumors in vitro and in vivo using epitope-defined monoclonal antibodies. Prog Brain Res. 101:213–223. 1994. View Article : Google Scholar

25 

Gaini SM, Riboni L, Cerri C, Grimoldi N, Sganzerla EP and Berra B: Ganglioside content and composition in human gliomas. Acta Neurochir Suppl (Wien). 43:126–129. 1988.

26 

Kawai K, Takahashi H, Watarai S, Ishizu H, Fukai K, Tanabe Y, Nose S and Kuroda S: Occurrence of ganglioside GD3 in neoplastic astrocytes. An immunocytochemical study in humans Virchows Arch. 434:201–205. 1999.

27 

Wagener R, Röhn G, Schillinger G, Schröder R, Kobbe B and Ernestus RI: Ganglioside profiles in human gliomas: Quantification by microbore high performance liquid chromatography and correlation to histomorphology and grading. Acta Neurochir (Wien). 141:1339–1345. 1999. View Article : Google Scholar

28 

Vukelić Z, Kalanj-Bognar S, Froesch M, Bîndila L, Radić B, Allen M, Peter-Katalinić J and Zamfir AD: Human gliosarcomaassociated ganglioside composition is complex and distinctive as evidenced by high-performance mass spectrometric determination and structural characterization. Glycobiology. 17:504–515. 2007. View Article : Google Scholar

29 

Ohkawa Y, Momota H, Kato A, Hashimoto N, Tsuda Y, Kotani N, Honke K, Suzumura A, Furukawa K, Ohmi Y, et al: Ganglioside GD3 enhances invasiveness via Yes activation by forming a complex of GD3/PDGFRα/Yes in gliomas. J Biol Chem. 290:16043–16058. 2015. View Article : Google Scholar : PubMed/NCBI

30 

Svennerholm L: Chromatographic separation of human brain gangliosides. J Neurochem. 10:613–623. 1963. View Article : Google Scholar : PubMed/NCBI

31 

Zhao J and Furukawa K, Fukumoto S, Okada M, Miyazaki H, Shiku H, Aizawa S, Matsuyama M and Furukawa K: Attenuation of the interleukin 2 signals in complex gangliosidelacking mice. J Biol Chem. 274:13744–13747. 1999. View Article : Google Scholar : PubMed/NCBI

32 

Allen M, Bjerke M, Edlund H, Nelander S and Westermark B: Origin of the U87MG glioma cell line: Good news and bad news. Sci Transl Med. 8:354re32016. View Article : Google Scholar : PubMed/NCBI

33 

Bady P, Diserens AC, Castella V, Kalt S, Heinimann K, Hamou MF, Delorenzi M and Hegi ME: DNA fingerprinting of glioma cell lines and considerations on similarity measurements. Neuro Oncol. 14:701–711. 2012. View Article : Google Scholar : PubMed/NCBI

34 

Haraguchi M, Yamashiro S, Yamamoto A and Furukawa K, Takamiya K, Lloyd KO, Shiku H and Furukawa K: Isolation of GD3 synthase gene by expression cloning of GM3 alpha-2,8-si-alyltransferase cDNA using anti-GD2 monoclonal antibody. Proc Natl Acad Sci USA. 91:10455–10459. 1994. View Article : Google Scholar

35 

Hamamura K, Furukawa K, Hayashi T, Hattori T, Nakano J, Nakashima H, Okuda T, Mizutani H, Hattori H, Ueda M, et al: Ganglioside GD3 promotes cell growth and invasion through p130Cas and paxillin in malignant melanoma cells. Proc Natl Acad Sci USA. 102:11041–11046. 2005. View Article : Google Scholar : PubMed/NCBI

36 

Aixinjueluo W and Furukawa K, Zhang Q, Hamamura K, Tokuda N, Yoshida S, Ueda R and Furukawa K: Mechanisms for the apoptosis of small cell lung cancer cells induced by anti-GD2 monoclonal antibodies: Roles of anoikis. J Biol Chem. 280:29828–29836. 2005. View Article : Google Scholar : PubMed/NCBI

37 

Rao JS: Molecular mechanisms of glioma invasiveness: The role of proteases. Nat Rev Cancer. 3:489–501. 2003. View Article : Google Scholar : PubMed/NCBI

38 

Hakomori SI: Cell adhesion/recognition and signal transduction through glycosphingolipid microdomain. Glycoconj J. 17:143–151. 2000. View Article : Google Scholar

39 

Kim OS, Park EJ, Joe EH and Jou I: JAK-STAT signaling mediates gangliosides-induced inflammatory responses in brain microglial cells. J Biol Chem. 277:40594–40601. 2002. View Article : Google Scholar : PubMed/NCBI

40 

Gabellini N, Facci L, Milani D, Negro A, Callegaro L, Skaper SD and Leon A: Differences in induction of c-fos transcription by cholera toxin-derived cyclic AMP and Ca2+ signals in astrocytes and 3T3 fibroblasts. Exp Cell Res. 194:210–217. 1991. View Article : Google Scholar : PubMed/NCBI

41 

Song N, Kim SJ, Kwon HY, Son SW, Kim KS, Ahn HB and Lee YC: Transcriptional activation of human GM3 synthase (hST3Gal V) gene by valproic acid in ARPE-19 human retinal pigment epithelial cells. BMB Rep. 44:405–409. 2011. View Article : Google Scholar : PubMed/NCBI

42 

Wang J and Yu RK: Interaction of ganglioside GD3 with an EGF receptor sustains the self-renewal ability of mouse neural stem cells in vitro. Proc Natl Acad Sci USA. 110:19137–19142. 2013. View Article : Google Scholar : PubMed/NCBI

43 

Fukumoto S, Mutoh T, Hasegawa T, Miyazaki H, Okada M, Goto G and Furukawa K, Urano T and Furukawa K: GD3 synthase gene expression in PC12 cells results in the continuous activation of TrkA and ERK1/2 and enhanced proliferation. J Biol Chem. 275:5832–5838. 2000. View Article : Google Scholar : PubMed/NCBI

44 

Ohkawa Y, Miyazaki S, Miyata M, Hamamura K and Furukawa K and Furukawa K: Essential roles of integrin-mediated signaling for the enhancement of malignant properties of melanomas based on the expression of GD3. Biochem Biophys Res Commun. 373:14–19. 2008. View Article : Google Scholar : PubMed/NCBI

45 

Hamamura K, Tsuji M, Ohkawa Y, Nakashima H, Miyazaki S, Urano T, Yamamoto N, Ueda M and Furukawa K and Furukawa K: Focal adhesion kinase as well as p130Cas and paxillin is crucially involved in the enhanced malignant properties under expression of ganglioside GD3 in melanoma cells. Biochim Biophys Acta. 1780:513–519. 2008. View Article : Google Scholar

46 

Valentino LA and Ladisch S: Tumor gangliosides enhance alpha2 beta1 integrin-dependent platelet activation. Biochim Biophys Acta. 1316:19–28. 1996. View Article : Google Scholar : PubMed/NCBI

47 

Ohkawa Y, Miyazaki S, Hamamura K, Kambe M, Miyata M, Tajima O, Ohmi Y, Yamauchi Y and Furukawa K and Furukawa K: Ganglioside GD3 enhances adhesion signals and augments malignant properties of melanoma cells by recruiting integrins to glycolipid-enriched microdomains. J Biol Chem. 285:27213–27223. 2010. View Article : Google Scholar : PubMed/NCBI

48 

Kaneko K, Ohkawa Y, Hashimoto N, Ohmi Y, Kotani N, Honke K, Ogawa M, Okajima T and Furukawa K and Furukawa K: Neogenin defined as a GD3-associated molecule by enzyme-mediated activation of radical sources confers malignant properties via intra-cytoplasmic domain in melanoma cells. J Biol Chem. 291:16630–16643. 2016. View Article : Google Scholar : PubMed/NCBI

49 

Guo G, Gong K, Wohlfeld B, Hatanpaa KJ, Zhao D and Habib AA: Ligand-independent EGFR signaling. Cancer Res. 75:3436–3441. 2015. View Article : Google Scholar : PubMed/NCBI

50 

Comoglio PM, Boccaccio C and Trusolino L: Interactions between growth factor receptors and adhesion molecules: Breaking the rules. Curr Opin Cell Biol. 15:565–571. 2003. View Article : Google Scholar : PubMed/NCBI

51 

Dae HM, Kwon HY, Kang NY, Song NR, Kim KS, Kim CH, Lee JH and Lee YC: Isolation and functional analysis of the human glioblastoma-specific promoter region of the human GD3 synthase (hST8Sia I) gene. Acta Biochim Biophys Sin (Shanghai). 41:237–245. 2009. View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Iwasawa T, Zhang P, Ohkawa Y, Momota H, Wakabayashi T, Ohmi Y, Bhuiyan RH, Furukawa K and Furukawa K: Enhancement of malignant properties of human glioma cells by ganglioside GD3/GD2. Int J Oncol 52: 1255-1266, 2018.
APA
Iwasawa, T., Zhang, P., Ohkawa, Y., Momota, H., Wakabayashi, T., Ohmi, Y. ... Furukawa, K. (2018). Enhancement of malignant properties of human glioma cells by ganglioside GD3/GD2. International Journal of Oncology, 52, 1255-1266. https://doi.org/10.3892/ijo.2018.4266
MLA
Iwasawa, T., Zhang, P., Ohkawa, Y., Momota, H., Wakabayashi, T., Ohmi, Y., Bhuiyan, R. H., Furukawa, K., Furukawa, K."Enhancement of malignant properties of human glioma cells by ganglioside GD3/GD2". International Journal of Oncology 52.4 (2018): 1255-1266.
Chicago
Iwasawa, T., Zhang, P., Ohkawa, Y., Momota, H., Wakabayashi, T., Ohmi, Y., Bhuiyan, R. H., Furukawa, K., Furukawa, K."Enhancement of malignant properties of human glioma cells by ganglioside GD3/GD2". International Journal of Oncology 52, no. 4 (2018): 1255-1266. https://doi.org/10.3892/ijo.2018.4266
Copy and paste a formatted citation
x
Spandidos Publications style
Iwasawa T, Zhang P, Ohkawa Y, Momota H, Wakabayashi T, Ohmi Y, Bhuiyan RH, Furukawa K and Furukawa K: Enhancement of malignant properties of human glioma cells by ganglioside GD3/GD2. Int J Oncol 52: 1255-1266, 2018.
APA
Iwasawa, T., Zhang, P., Ohkawa, Y., Momota, H., Wakabayashi, T., Ohmi, Y. ... Furukawa, K. (2018). Enhancement of malignant properties of human glioma cells by ganglioside GD3/GD2. International Journal of Oncology, 52, 1255-1266. https://doi.org/10.3892/ijo.2018.4266
MLA
Iwasawa, T., Zhang, P., Ohkawa, Y., Momota, H., Wakabayashi, T., Ohmi, Y., Bhuiyan, R. H., Furukawa, K., Furukawa, K."Enhancement of malignant properties of human glioma cells by ganglioside GD3/GD2". International Journal of Oncology 52.4 (2018): 1255-1266.
Chicago
Iwasawa, T., Zhang, P., Ohkawa, Y., Momota, H., Wakabayashi, T., Ohmi, Y., Bhuiyan, R. H., Furukawa, K., Furukawa, K."Enhancement of malignant properties of human glioma cells by ganglioside GD3/GD2". International Journal of Oncology 52, no. 4 (2018): 1255-1266. https://doi.org/10.3892/ijo.2018.4266
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team